Diagnostic Accuracy of Gallium-68-DOTATATE PET/CT Compared to Indium-111-pentetreotide Scintigraphy (SPECT/CT) for Gastroenteropancreatic Neuroendocrine Tumors
Clinical trial NCT02078843 · TERMINATED
Trial details
- NCT number
- NCT02078843
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2016-08-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.